SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ekso Bionics Holdings, Inc. (EKSO)

NEW YORK, Dec. 28, 2017

The investigation concerns whether Ekso and certain of its officers and/or directors have violated Sections federal securities laws.

On December 14, 2017, Ekso advised investors that "the Company's internal control over financial reporting as of December 31, 2016 should no longer be relied upon and that a material weakness in the Company's internal control over financial reporting existed as of such date.."  On this news, Ekso's share price fell $0.15, or 6.17%, to close at $2.28 on December 15, 2017.  On December 27, 2017, post-market, Ekso filed an amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017.  On this news, Ekso's share price has fallen sharply during intraday trading on December 28, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of Ekso, you can assist this investigation by visiting the firm's site: www.bgandg.com/ekso. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com